Figures & data
Figure 1. Naringin inhibited RANTES production by HaCaT cells stimulated with tumor necrosis factor alpha (TNF-α)/interferon gamma (IFN-γ) at 48 h (n = 3).
Figure 2. Naringin decreased the relative fold change of RANTES gene in HaCaT cells stimulated with tumor necrosis factor alpha (TNF-α)/interferon gamma (IFN-γ).
Figure 3. Naringin decreased the expression of nuclear factor kappa B (NF-κB) p65 in nuclear extracts of HaCaT cells in western blot. 1, Untreated HaCaT cells, 2, cells treated with 0.5 mmol/L naringin, 3, cells stimulated with tumor necrosis factor alpha (TNF-α)/interferon gamma (IFN-γ). #Compared with untreated cells, P < 0.02. *Compared with cells stimulated with TNF-α/IFN-γ, P < 0.01.
Figure 4. Nuclear factor kappa B (NF-κB) P65-positive expression in HaCaT cells (SP × 400). (A) NF-κB P65-positive expression in cytoplasm of normal cells, (B) NF-κB P65-positive expression in nuclei of some cells stimulated with tumor necrosis factor alpha (TNF-α)/interferon gamma (IFN-γ) for 0.5 h, and (C) NF-κB p65 expression in cytoplasm of cells stimulated with 0.5 mmol/L naringin for 16 h and TNF-α/IFN-γ for 0.5 h.
